Le Lézard
Classified in: Health, Science and technology, Business
Subject: FINANCING AGREEMENTS

H-Source Announces Closing of $1.725 Million Brokered Private Placement


VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 4, 2018) - H-Source Holdings Ltd. (TSX VENTURE:HIS)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce that, further to its news release of December 22, 2017, it has completed its private placement offering (the "Offering") of common shares of the Company pursuant to an agency agreement dated January 4, 2018 between H-Source and Mackie Research Capital Corporation as lead agent and sole book-runner (the "Agent"). Pursuant to the Offering, H-Source sold an aggregate 17,250,000 common shares at a price of C$0.10 per common share for aggregate gross proceeds of C$1,725,000, which includes 2,250,000 common shares sold pursuant an over-allotment option granted to the Agent which was exercised in full.

In consideration of the services rendered by the Agent in connection with the Offering, the Agent received from the Company a commission equal to 7.5% of the gross proceeds arising from the Offering, subject to certain exclusions. As additional compensation, the Agent were issued non-transferable warrants (the "Compensation Options") to acquire common shares from treasury in an amount equal to 7.5% of the common shares issued pursuant to the Offering, subject to certain exclusions. The Compensation Options are exercisable at a price of C$0.10 per Compensation Option until July 4, 2019.

The net proceeds of the Offering will be used for general working capital purposes.

All of the securities of the Company issued under the Offering are subject to a hold period which will expire on May 5, 2018 in accordance with applicable Canadian securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and any applicable state securities laws or an exemption from such registration requirements is available.

About H-Source Holdings Ltd.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and trusted marketplace for member hospitals to buy, sell and transfer excess inventory supplies and capital equipment with each other. Member hospitals can conduct secure transactions within Integrated Delivery Networks, complete H-Source network or customize their own group hospitals using H-Source's built-in filters. This marketplace network is specifically designed to reduce health care costs and medical product waste. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice, CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: 

Neither TSX Venture Exchange (TSXV) nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements relating to the completion of the Offering and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.


These press releases may also interest you

at 00:17
Avirmax Inc., will make two scientific presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) annual meeting in Baltimore between May 7th and 11th, 2024. In addition, Avirmax will have an exhibitor booth #818 to showcase the...

at 00:16
The National Council for Incarcerated and Formerly Incarcerated Women and Girls understands the BOP has decided to close FCI Dublin. The only humane and ethical way to atone for the atrocities perpetrated there is to let the women who suffered go...

at 00:01
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today revealed its 2024 Best Senior Living ratings to assist seniors and their families with researching and choosing the best senior living community for their...

15 avr 2024
Hudson Mind, an interventional mental health clinic in New York City, announces the addition of Spravato® (https://mind.hudson.health/treatments/spravato/). The integration of Spravato opens the door to more accessible treatment options for patients...

15 avr 2024
The report titled "Active Nutraceuticals Ingredients Market by Type (Carotenoids, Fibers & Specialty Carbohydrates, Minerals), Form (Dry, Liquid), Health Benefit, Application, Distribution Channel - Global Forecast 2024-2030" is now available on...

15 avr 2024
The report titled "Multicancer Screening Market by Product (AI and Machine Learning-Based Platforms, Blood-Based Tests, Breath Analysis Tests), Test Type (In-vitro diagnostics, Laboratory Developed Tests), Technology, Cancer Type, End User - Global...



News published on and distributed by: